Spring 2020, Volume 2, Number 1
Healthcare
In this Chronicle we turn to the timely issue of healthcare and competition.
In light of the COVID-19 pandemic, the healthcare industry, in all its facets, including the development of pharmaceuticals, the provision of healthcare, and health insurance, has never been as vital. Antitrust rules have a key role to play to ensure that drug companies continue to innovate, vital care is provided to the public, and, above all, that patients receive the care they need.
